Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Mercedes boss Wolff says Formula One 'second priority' amid Middle East crisis Mercedes boss Toto Wolff hopes Formula One's races in Bahrain and Saudi Arabia can go ahead but said the motor sport ...

The 2026 Formula 1 season starts at Melbourne Park with the Australian Grand Prix on the weekend of March 6-8. Lando Norris became world champion for the first time in 2025 after finishing third at a ...

Considered to be the pinnacle of motorsport, Formula One has amassed a huge global fanbase thanks to its enthralling mix of high-octane action and sporting drama. Merging cutting-edge technology with ...

ROI is an important measure of an investment's performance but it has some drawbacks. Andrew Beattie was part of the original editorial team at Investopedia and has spent twenty years writing on a ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...